The integration of upfront cranial radiotherapy (RT) with EGFR-TKIs in the management of EGFR-mutated NSCLC with brain metastases remains a complex and evolving area of clinical discussion, with an ongoing debate regarding optimal sequencing, especially with newer TKI generations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.